Evolv Technologies Holdings (EVLV) Could Be 39% Undervalued As Stadium Deal Adds Traction
Evolv Technologies Holdings (EVLV) just landed a multi-year role as the official fan screening provider for Northwestern University’s new Ryan Field, placing its Evolv Express system at the center of a high-visibility stadium opening.
See our latest analysis for Evolv Technologies Holdings.
That new Ryan Field contract arrives during a mixed period for Evolv Technologies Holdings, with the share price at US$6.13 after a 10.85% 7 day share price return but a year to date share price return that is down 8.51%, and a 1 year total shareholder return that is down 15.91%. This indicates that near term momentum has picked up, while longer term performance has been weaker.
If this stadium deal has you thinking about where security and AI could go next, it is a good time to scan the wider market using the 33 AI small caps.
Evolv Technologies Holdings now trades well below the average analyst price target, even after the recent bounce. Is that a sign the market is being too cautious about its losses and risks, or a warning worth heeding as you assess valuation next?
Most Popular Narrative: 38.7% Undervalued
At a last close of $6.13 against a narrative fair value of $10.00, Evolv Technologies Holdings is framed as having a sizeable valuation gap that analysts connect directly to recurring contracts and margin improvements.
The increasing prevalence of large multi-year contracts with public school systems and hospitals, driven by heightened public safety concerns in high-density environments, is expanding Evolv's total addressable market and should support outsized revenue growth over the coming years. Growing customer adoption and frequent upgrades to newer platforms like Gen2 and eXpedite reflect a successful technology road map that is boosting customer retention rates and fostering longer-term subscription commitments, positively impacting both ARR and net margins.
Want to see why this fair value sits well above today’s price? The core of the narrative is aggressive revenue compounding, rising margins and a future earnings multiple that assumes strong investor enthusiasm. Curious which specific growth and profitability targets need to line up for that story to hold?
Based on this widely followed narrative, analysts apply an 8.47% discount rate and expect revenue expansion, margin improvement and a rich future P/E multiple to support a fair value of $10.00 per share. That implies a meaningful gap versus the current $6.13 share price that depends on Evolv Technologies Holdings executing on multi year contracts, subscription growth and cost control in the years ahead.
Result: Fair Value of $10.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Evolv Technologies Holdings still faces risks if hardware heavy direct sales pressure margins or if growth across key sectors like education and healthcare slows.
Find out about the key risks to this Evolv Technologies Holdings narrative.
Another View: What Multiples Say About Evolv Technologies Holdings
The earlier fair value of $10.00 for Evolv Technologies Holdings leans heavily on growth and margin forecasts. By contrast, the current P/S of 6.9x looks expensive next to the US Electronic industry at 2.8x and a fair ratio of 3.2x, even though it sits below the 8.9x peer average. Is the market overpaying for the story, or is it simply pricing in sector norms?
For a closer look at how these ratios stack up and what they might mean for valuation risk, review the See what the numbers say about this price — find out in our valuation breakdown..
Next Steps
Given the mix of optimism and concern around Evolv Technologies Holdings, this is a moment to look at the numbers yourself and decide how comfortable you are with both sides of the story. To see the balance of potential upside and the areas that could hold the stock back, start with the 2 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Evolv Technologies Holdings?
If Evolv Technologies Holdings has sharpened your focus on where capital could work harder, do not stop at a single stock. Cast a wider net and pressure test your next ideas using focused screeners that surface clear financial traits.
- Target potential mispricings by scanning companies that combine quality fundamentals with attractive valuations using the 52 high quality undervalued stocks.
- Strengthen your income stream by reviewing stocks that offer higher yields and resilient payouts with the 8 dividend fortresses.
- Dial down portfolio risk by checking companies that clear tough balance sheet and fundamentals filters through the solid balance sheet and fundamentals stocks screener (48 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Evolv Technologies Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com